世界のバイオ医薬品受託製造（BCMO）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Biopharmaceutical Contract Manufacturing(BCMO) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12098 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、バイオ医薬品受託製造（BCMO）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオ医薬品受託製造（BCMO）の種類別市場規模（哺乳類製造、微生物製造、その他）、用途別市場規模（バイオ製薬会社、製薬会社、創薬会社、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・バイオ医薬品受託製造（BCMO）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Lonza Group Ltd、Boehringher Ingelheim、Sandoz、Fujifilm Diosynth Biotechnology、Rentschler Biotechnologie、Celonic GmbH、BIOMEVA GmbH、ProBioGen AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：哺乳類製造、微生物製造、その他 ・用途別分析2016年-2026年：バイオ製薬会社、製薬会社、創薬会社、その他 ・バイオ医薬品受託製造（BCMO）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・バイオ医薬品受託製造（BCMO）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・バイオ医薬品受託製造（BCMO）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バイオ医薬品受託製造（BCMO）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・バイオ医薬品受託製造（BCMO）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Biopharmaceutical Contract Manufacturing(BCMO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biopharmaceutical Contract Manufacturing(BCMO) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Biopharmaceutical Contract Manufacturing(BCMO) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Biopharmaceutical Contract Manufacturing(BCMO) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Mammalian Based Manufacturing
Microbial Based Manufacturing
Other

Market segment by Application, can be divided into
Bio-Pharmaceutical Companies
Pharmaceutical Companies
Drug Discovery Companies
Other

Market segment by players, this report covers
Lonza Group Ltd
Boehringher Ingelheim
Sandoz
Fujifilm Diosynth Biotechnology
Rentschler Biotechnologie
Celonic GmbH
BIOMEVA GmbH
ProBioGen AG

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biopharmaceutical Contract Manufacturing(BCMO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biopharmaceutical Contract Manufacturing(BCMO), with revenue, gross margin and global market share of Biopharmaceutical Contract Manufacturing(BCMO) from 2019 to 2021.
Chapter 3, the Biopharmaceutical Contract Manufacturing(BCMO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Biopharmaceutical Contract Manufacturing(BCMO) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Biopharmaceutical Contract Manufacturing(BCMO) research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Contract Manufacturing(BCMO)
1.2 Classification of Biopharmaceutical Contract Manufacturing(BCMO) by Type
1.2.1 Overview: Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type in 2020
1.2.3 Mammalian Based Manufacturing
1.2.4 Microbial Based Manufacturing
1.2.5 Other
1.3 Global Biopharmaceutical Contract Manufacturing(BCMO) Market by Application
1.3.1 Overview: Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Bio-Pharmaceutical Companies
1.3.3 Pharmaceutical Companies
1.3.4 Drug Discovery Companies
1.3.5 Other
1.4 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size & Forecast
1.5 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast by Region
1.5.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region, (2016-2021)
1.5.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Prospect (2016-2026)
1.5.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Prospect (2016-2026)
1.5.6 South America Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Drivers
1.6.2 Biopharmaceutical Contract Manufacturing(BCMO) Market Restraints
1.6.3 Biopharmaceutical Contract Manufacturing(BCMO) Trends Analysis
2 Company Profiles
2.1 Lonza Group Ltd
2.1.1 Lonza Group Ltd Details
2.1.2 Lonza Group Ltd Major Business
2.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.1.4 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Lonza Group Ltd Recent Developments and Future Plans
2.2 Boehringher Ingelheim
2.2.1 Boehringher Ingelheim Details
2.2.2 Boehringher Ingelheim Major Business
2.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.2.4 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Boehringher Ingelheim Recent Developments and Future Plans
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.3.4 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sandoz Recent Developments and Future Plans
2.4 Fujifilm Diosynth Biotechnology
2.4.1 Fujifilm Diosynth Biotechnology Details
2.4.2 Fujifilm Diosynth Biotechnology Major Business
2.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.4.4 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Fujifilm Diosynth Biotechnology Recent Developments and Future Plans
2.5 Rentschler Biotechnologie
2.5.1 Rentschler Biotechnologie Details
2.5.2 Rentschler Biotechnologie Major Business
2.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.5.4 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Rentschler Biotechnologie Recent Developments and Future Plans
2.6 Celonic GmbH
2.6.1 Celonic GmbH Details
2.6.2 Celonic GmbH Major Business
2.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.6.4 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Celonic GmbH Recent Developments and Future Plans
2.7 BIOMEVA GmbH
2.7.1 BIOMEVA GmbH Details
2.7.2 BIOMEVA GmbH Major Business
2.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.7.4 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BIOMEVA GmbH Recent Developments and Future Plans
2.8 ProBioGen AG
2.8.1 ProBioGen AG Details
2.8.2 ProBioGen AG Major Business
2.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
2.8.4 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 ProBioGen AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biopharmaceutical Contract Manufacturing(BCMO) Players Market Share
3.2.2 Top 10 Biopharmaceutical Contract Manufacturing(BCMO) Players Market Share
3.2.3 Market Competition Trend
3.3 Biopharmaceutical Contract Manufacturing(BCMO) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Market Share by Type (2016-2021)
4.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application (2016-2021)
5.2 Biopharmaceutical Contract Manufacturing(BCMO) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2026)
6.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2026)
6.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
6.3.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2026)
6.3.2 United States Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
6.3.3 Canada Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
6.3.4 Mexico Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2026)
7.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2026)
7.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
7.3.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2026)
7.3.2 Germany Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
7.3.3 France Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
7.3.5 Russia Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
7.3.6 Italy Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2026)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2026)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region
8.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Region (2016-2026)
8.3.2 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
8.3.3 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
8.3.4 South Korea Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
8.3.5 India Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
8.3.7 Australia Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2026)
9.2 South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2026)
9.3 South America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
9.3.1 South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2026)
9.3.2 Brazil Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
9.3.3 Argentina Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2026)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2026)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
10.3.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2026)
10.3.2 Turkey Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
10.3.4 UAE Biopharmaceutical Contract Manufacturing(BCMO) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biopharmaceutical Contract Manufacturing(BCMO) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Region (2021-2026)
Table 6. Lonza Group Ltd Corporate Information, Head Office, and Major Competitors
Table 7. Lonza Group Ltd Major Business
Table 8. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 9. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Boehringher Ingelheim Corporate Information, Head Office, and Major Competitors
Table 11. Boehringher Ingelheim Major Business
Table 12. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 13. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sandoz Corporate Information, Head Office, and Major Competitors
Table 15. Sandoz Major Business
Table 16. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 17. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Fujifilm Diosynth Biotechnology Corporate Information, Head Office, and Major Competitors
Table 19. Fujifilm Diosynth Biotechnology Major Business
Table 20. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 21. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Rentschler Biotechnologie Corporate Information, Head Office, and Major Competitors
Table 23. Rentschler Biotechnologie Major Business
Table 24. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 25. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Celonic GmbH Corporate Information, Head Office, and Major Competitors
Table 27. Celonic GmbH Major Business
Table 28. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 29. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BIOMEVA GmbH Corporate Information, Head Office, and Major Competitors
Table 31. BIOMEVA GmbH Major Business
Table 32. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 33. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. ProBioGen AG Corporate Information, Head Office, and Major Competitors
Table 35. ProBioGen AG Major Business
Table 36. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Product and Solutions
Table 37. ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) by Players (2019-2021)
Table 39. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Players (2019-2021)
Table 40. Breakdown of Biopharmaceutical Contract Manufacturing(BCMO) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Biopharmaceutical Contract Manufacturing(BCMO) Players Head Office, Products and Services Provided
Table 42. Biopharmaceutical Contract Manufacturing(BCMO) Mergers & Acquisitions in the Past Five Years
Table 43. Biopharmaceutical Contract Manufacturing(BCMO) New Entrants and Expansion Plans
Table 44. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) by Type (2016-2021)
Table 45. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Type (2016-2021)
Table 46. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Forecast by Type (2021-2026)
Table 47. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2021)
Table 48. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Forecast by Application (2021-2026)
Table 49. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biopharmaceutical Contract Manufacturing(BCMO) Picture
Figure 2. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type in 2020
Figure 3. Mammalian Based Manufacturing
Figure 4. Microbial Based Manufacturing
Figure 5. Other
Figure 6. Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application in 2020
Figure 7. Bio-Pharmaceutical Companies Picture
Figure 8. Pharmaceutical Companies Picture
Figure 9. Drug Discovery Companies Picture
Figure 10. Other Picture
Figure 11. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Region (2016-2026)
Figure 14. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Region in 2020
Figure 15. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Biopharmaceutical Contract Manufacturing(BCMO) Market Drivers
Figure 21. Biopharmaceutical Contract Manufacturing(BCMO) Market Restraints
Figure 22. Biopharmaceutical Contract Manufacturing(BCMO) Market Trends
Figure 23. Lonza Group Ltd Recent Developments and Future Plans
Figure 24. Boehringher Ingelheim Recent Developments and Future Plans
Figure 25. Sandoz Recent Developments and Future Plans
Figure 26. Fujifilm Diosynth Biotechnology Recent Developments and Future Plans
Figure 27. Rentschler Biotechnologie Recent Developments and Future Plans
Figure 28. Celonic GmbH Recent Developments and Future Plans
Figure 29. BIOMEVA GmbH Recent Developments and Future Plans
Figure 30. ProBioGen AG Recent Developments and Future Plans
Figure 31. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Players in 2020
Figure 32. Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share in 2020
Figure 34. Global Top 10 Players Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Type in 2020
Figure 37. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share Forecast by Type (2021-2026)
Figure 38. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Share by Application in 2020
Figure 39. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share Forecast by Application (2021-2026)
Figure 40. North America Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Type (2016-2026)
Figure 41. North America Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Application (2016-2026)
Figure 42. North America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Country (2016-2026)
Figure 43. United States Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Type (2016-2026)
Figure 47. Europe Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Application (2016-2026)
Figure 48. Europe Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Country (2016-2026)
Figure 49. Germany Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Region (2016-2026)
Figure 57. China Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Type (2016-2026)
Figure 64. South America Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Application (2016-2026)
Figure 65. South America Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Biopharmaceutical Contract Manufacturing(BCMO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source

---